CircDOCK1

ncRNA information

ncRNA name

CircDOCK1

Specific or universal ncRNAs

Specific ncRNAs

Class

Circular RNA

Biomarker

None

Biomarker application

Upstream regulatory factors

Not available

Downstream target

miR-339-3p/IGF1R

Cancer information

Cancer name

Osteosarcoma

Cancer site

qRT-PCR,Western blot,Luciferase assay

Treatment information

Treatment type

Chemotherapy

Drug

Cisplatin

Impact of wild-type ncRNA on chemotherapy resistance

Up

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Up

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

CircDOCK1 promotes the tumorigenesis and cisplatin resistance of osteogenic sarcoma via the miR-339-3p/IGF1R axis

Tissue resource

osteosarcoma tissues and paracancerous tissues

human normal osteoblastic cell lines hFOB 1.19

human osteosarcoma cell lines MG63

human osteosarcoma cell lines SaOS-2

human osteosarcoma cell lines U2OS

human osteosarcoma cell lines HOS

Experiment

None


Institute

Cancer Hospital of China Medical University

the Cell Bank of the Chinese Academy of Sciences

Country

China

China

Continent

Asia

Asia